Analyst firms · Imperial Capital · HIMS

Imperial Capital HIMS price target and rating history

Hims & Hers Health Inc. (HIMS) · Health Care

Imperial Capital rates Hims & Hers Health Inc. (HIMS) In-line with a $16 price target, as of its latest action on Aug 9, 2024. It has published 3 rating actions on HIMS since December 2023, including 1 upgrade and 1 downgrade. Across 5 firms with a HIMS price target in the last 12 months, the median target is $33.

Current rating
In-line
Price target
$16
Median target, all firms
$33
Actions on HIMS
3

Imperial Capital price target on HIMS

$16$13$9202420252026
Imperial Capital price target on HIMS, each point a stated target, December 2023 to February 2024.

Every Imperial Capital rating on HIMS

How other firms rate HIMS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
NeedhamBuy$35May 12, 2026
CitigroupNeutral$24Mar 10, 2026
BofA SecuritiesNeutral$23Mar 10, 2026
BTIGNeutralFeb 24, 2026
Evercore ISIIn-line$33Jan 12, 2026
BarclaysOverweight$48Dec 9, 2025

Questions about Imperial Capital and HIMS

What is Imperial Capital's price target for HIMS?
Imperial Capital's latest stated price target for Hims & Hers Health Inc. (HIMS) is $16, from its action on Feb 28, 2024.
What is Imperial Capital's rating on HIMS?
Imperial Capital rates HIMS In-line, a neutral rating, as of Aug 9, 2024.
When did Imperial Capital last change its view on HIMS?
On Aug 9, 2024, Imperial Capital downgrades to In-line from Outperform.
How does Imperial Capital's HIMS target compare with other analysts?
Across 5 firms with a HIMS price target in the last 12 months, the median target is $33.

More HIMS rating histories

All Imperial Capital ratingsHIMS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.